Grand Pharmaceutical Group Ltd Sustainability Reports
Grand Pharmaceutical Group Limited is an investment holding company primarily engaged in the development, manufacture, and sale of pharmaceutical preparations, medical devices, bio-technology products, and specialized raw materials. Its key clinical specialties include nuclear medicine anti-tumor therapies, cerebro-cardiovascular precision intervention, and respiratory and ophthalmic treatments.
Sector: Manufacturing
Country: Hong Kong
Exchange: Hong Kong Stock Exchange
LEI: 8945001XW4FS15S8Z778
FIGI: BBG001S7WFP5
11 reports from 2019 to 2025
- Grand Pharmaceutical Group Ltd 2025 Environmental, Social and Governance Report
- Grand Pharmaceutical Group Ltd 2024 Environmental, Social and Governance Report
- Grand Pharmaceutical Group Ltd 2024 Annual Report
- Grand Pharmaceutical Group Ltd 2024 Environmental, Social and Governance Report
- Grand Pharmaceutical Group Ltd 2023 Environmental, Social and Governance Report